HEALTH ECONOMICS IN THE FIELD OF PROSTHETICS AND ORTHOTICS: A GLOBAL PERSPECTIVE
Open Access
- 21 September 2021
- journal article
- Published by University of Toronto Libraries - UOTL in CANADIAN PROSTHETICS & ORTHOTICS JOURNAL
- Vol. 4 (2)
- https://doi.org/10.33137/cpoj.v4i2.35298
Abstract
The rapid advancement of prosthetic and orthotic (P&O) technology raises the question how the industry can ensure that patients have access to the benefits and providers get paid properly and fairly by healthcare payers. This is a challenge that not only P&O but all areas of health technology face. In many areas of medicine and health products, such as drugs and medical devices, health-technology assessments (HTA) have become a standard procedure in the coverage and reimbursement process. In most countries, P&O is lagging behind that development, although some countries have already formalized HTA for prosthetic and orthotic products and may even use cost-effectiveness analyses to determine pricing and payment amounts. This article gives an overview on the coverage and reimbursement processes in the United States, Canada, Germany, France, Sweden, the United Kingdom, Poland, Japan, and China. This selection reflects the variety and diversity of coverage and reimbursement processes that the P&O industry faces globally. The paper continues with an overview on the necessary research and investment efforts that manufacturers will have to make in the future, and contemplates the likely consequences for the manufacturer community in the market place. Health economics may help support the transition from price-based to value-based coverage and reimbursement but will come at considerable costs to the industry. Article PDF Link: https://jps.library.utoronto.ca/index.php/cpoj/article/view/35298/28317 How To Cite: Kannenberg A, Seidinger S. Health economics in the field of prosthetics and orthotics: A global perspective. Canadian Prosthetics & Orthotics Journal. 2021; Volume 4, Issue 2, No.6. https://doi.org/10.33137/cpoj.v4i2.35298 Corresponding Author: Andreas Kannenberg, MD (GER), PhD Executive Medical Director North America, Otto Bock Healthcare LP, 11501 Alterra Parkway, Suite 600, Austin, Texas, USA. E-Mail: andreas.kannenberg@ottobock.com ORCID ID: https://orcid.org/0000-0001-7983-1744Keywords
This publication has 34 references indexed in Scilit:
- Stratified cost-utility analysis of C-Leg versus mechanical kneesProsthetics and Orthotics International, 2017
- Implementation of the 2011 Reimbursement Act in Poland: Desired and undesired effects of the changes in reimbursement policyHealth Policy, 2016
- National Health Insurance Development in China from 2004 to 2011: Coverage versus BenefitsPLOS ONE, 2015
- Thresholds for the cost–effectiveness of interventions: alternative approachesBulletin of the World Health Organization, 2014
- Active dorsiflexing prostheses may reduce trip-related fall risk in people with transtibial amputationJournal of Rehabilitation Research and Development, 2014
- Toe clearance when walking in people with unilateral transtibial amputation: Effects of passive hydraulic ankleJournal of Rehabilitation Research and Development, 2014
- Economic Evaluation for Devices and Drugs—Same or Different?Value in Health, 2009
- Cost utility analysis of knee prosthesis with complete microprocessor control (C-leg) compared with mechanical technology in trans-femoral amputeesThe European Journal of Health Economics, 2008
- The NICE Cost-Effectiveness ThresholdPharmacoEconomics, 2008
- Definition of the “Health Benefit Basket” in PolandThe European Journal of Health Economics, 2005